The DEAH-box family of RNA-dependent NTPases (DHX) plays a crucial role in RNA metabolism, including processes such as splicing, ribosome biogenesis, and mRNA export from the nucleus. These proteins act as molecular motors that harness the energy from nucleotide hydrolysis to unwind or remodel RNA and RNA-protein complexes. The DHX proteins generally contain conserved motifs that are essential for ATP binding and hydrolysis, as well as RNA binding and unwinding. Through their ATPase and helicase activities, DHX proteins are able to dynamically regulate the structure and function of various RNA molecules and complexes, thereby influencing diverse cellular processes.
The class of molecules known as DEAH-box RNA-dependent NTPase (DHX) Inhibitors is specifically designed to modulate the activity of the DHX family of proteins, which are central to RNA metabolism in the cell. These inhibitors typically target the ATPase or helicase domains of DHX proteins, as these are the functional cores responsible for nucleotide binding, hydrolysis, and the subsequent RNA remodeling activities. Some inhibitors may act by binding directly to the ATPase pocket, thereby ATP from binding and disabling the enzyme's activity. Others may bind to regions of the protein that are essential for RNA interaction, therefore making the protein unable to engage with its natural RNA substrates. Some inhibitors are allosteric in nature and can bind to regions other than the active site, causing conformational changes that make the enzyme less effective or completely inactive.
VEJA TAMBÉM
Items 1 to 10 of 11 total
Mostrar:
Nome do Produto | CAS # | Numero de Catalogo | Quantidade | Preco | Uso e aplicacao | NOTAS |
---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Inibidor da PI3K que afecta as vias de processamento do ARN a jusante. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Inibe a síntese proteica, afectando indiretamente o processamento do ARN. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $80.00 $212.00 $408.00 | 48 | |
Inibe a JNK, que desempenha um papel no splicing do ARN. | ||||||
Akt Inhibitor IV | 681281-88-9 | sc-203809 sc-203809A | 5 mg 25 mg | $173.00 $695.00 | 42 | |
Inibe a Akt, que está envolvida no processamento do ARN. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inibidor da JNK que pode afetar o splicing do RNA. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $76.00 $216.00 | 101 | |
Influencia a função de helicases de ARN como a DDX38, causando danos no ADN. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $36.00 $149.00 | 11 | |
Interfere indiretamente com a atividade da RNA helicase ao perturbar o metabolismo dos nucleótidos. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $32.00 $170.00 $385.00 | 63 | |
Inibidor da topoisomerase II que afecta potencialmente o processamento do ARN. | ||||||
2′-Deoxy-2′,2′-difluorocytidine | 95058-81-4 | sc-275523 sc-275523A | 1 g 5 g | $56.00 $128.00 | ||
Interfere na síntese e reparação do ADN, afectando as hélices de ARN como a DDX38. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $57.00 $182.00 $92.00 | 21 | |
Inibidor da topoisomerase I que provoca danos no ADN que afectam as hélices de ARN como a DDX38. |